Early steps on the pathway to develop quality metrics that have an impact on postendoscopy upper gastrointestinal cancer rates

Gastrointest Endosc. 2022 Sep;96(3):476-478. doi: 10.1016/j.gie.2022.05.016. Epub 2022 Jul 16.

Authors

Zoe Post¹, Joshua Melson¹

Affiliation

¹ Division of Digestive Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.

PMID: 35850861
DOI: 10.1016/j.gie.2022.05.016

No abstract available

Publication types

Editorial
Comment

MeSH terms

Benchmarking
Gastrointestinal Neoplasms* / epidemiology
Humans
Upper Gastrointestinal Tract*